Evaluation of oral erosion and prevention by Hangeshashinto in chemotherapy for esophageal cancer
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000006201
- Lead Sponsor
- Chiba university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
1) no prior history of allergy in Hangeshashinto 2) patients to undergo other regimen of chemotherapy 3) no prior other Kanpo-drugs administered 4) severe organ failures 5) no prior history of opioids or steroidal treatments 6) active infection 7) concomitant active cancers 8) severe allergy for other drugs 9) patients who want to be pregnant or pregnant woman 10) severe constipation 11) pulmonary fibrosis 12) severe pshychological disorder 13) inappropriate cases for a clinical trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of oral erosion
- Secondary Outcome Measures
Name Time Method